n | % who correctly identified the firstline anti-malarial therapy | Unadjusted odds ratio (95% confidence interval; P value) | ||
---|---|---|---|---|
Malaria training | ||||
Attended malaria workshop | ||||
Yes | 46 | 65% | 0.94 (0.42 - 2.07; 0.873) | |
No | 66 | 67% | Ref | |
Attended malaria workshop after 2006 | ||||
Yes | 34 | 62% | 0.32 (0.06 - 1.71; 0.184) | |
No | 12 | 83% | Ref | |
Received drug information from MOH | ||||
Yes | 94 | 69% | 0.96 (0.85 - 1.08; 0.483) | |
No | 19 | 53% | Ref | |
Dispensing Practices | ||||
Recommended AL for uncomplicated malaria in children under 5 | ||||
Yes | 43 | 74% | 2.41 (1.01 - 5.76; 0.048)* | |
No | 53 | 55% | Ref | |
Recommend AL for uncomplicated malaria in adults | ||||
Yes | 55 | 76% | 3.55 (1.49 - 8.47; 0.004)* | |
No | 42 | 48% | Ref | |
Table 4 b: Relationship between shop worker recommendation of AL to children under 5 and their response to clinical scenarios | ||||
n | % who would recommend AL to children under 5 | Unadjusted odds ratio and (95% confidence interval; P value) | ||
Paediatric Case Management** | ||||
Refer pediatric patients rather than treat | ||||
Yes | 43 | 49% | 2.45 (1.04 - 5.79; 0.041)* | |
No | 65 | 31% | Ref | |
Refuse Fansidar to a mother requesting it | ||||
Yes | 94 | 67% | 3.59 (1.08 - 11.90; 0.036)* | |
No | 19 | 58% | Ref |